William A. Schumacher

2.8k citations

82 papers · 2.0k indexed · h-index 27

Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms 24
Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 11
Genetics top 1%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 21
Cardiology and Cardiovascular Medicine top 5%
- Antiplatelet Therapy and Cardiovascular Diseases 18
- Atrial Fibrillation Management and Outcomes 8
Biochemistry top 5%
Physiology
- Nitric Oxide and Endothelin Effects 10
Pharmacology
- Inflammatory mediators and NSAID effects 10
Pathology and Forensic Medicine
- Cardiac Ischemia and Reperfusion 9

Co-authors: Martin L. Ogletree Patricia L. Smith Thomas E. Steinbacher Dietmar Seiffert Benedict R. Lucchesi Christopher L. Heran M‐Y. HSU David Gailani
Cited by: Hematology Internal Medicine Genetics
Journals: Circulation (1 paper)Blood (1 paper)Journal of the American College of Cardiology (1 paper)
Partner nations: United States Germany Sweden

In The Last Decade

William A. Schumacher

80 papers receiving 1.9k citations

Peers

Countries citing papers authored by William A. Schumacher

Since Specialization

Citations

This map shows the geographic impact of William A. Schumacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Schumacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Schumacher more than expected).

Fields of papers citing papers by William A. Schumacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Schumacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Schumacher. The network helps show where William A. Schumacher may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William A. Schumacher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William A. Schumacher Line = papers co-authored together William A. Schumacher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of a Hydroxypyrimidinone Compound (21) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure Journal of Medicinal Chemistry ·Wei Meng,Zulan Pi,Robert Brigance,Karen A. Rossi,William A. Schumacher,Jeffrey S. Bostwick,Peter S. Gargalovic,Joelle M. Onorato,Chiuwa E. Luk,Claudia Generaux,Tao Wang,Ruth R. Wexler,Heather J. Finlay	2021	7
2	Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold Bioorganic & Medicinal Chemistry Letters ·Scott A. Bolton,James Sutton,Rushith Anumula,Gregory S. Bisacchi,Bruce L. Jacobson,William A. Slusarchyk,Uwe Treuner,Shung Wu,Guohua Zhao,Zulan Pi,S. Sheriff,Rebecca A. Smirk,Sharon N. Bisaha,Daniel L. Cheney,Anzhi Wei,William A. Schumacher,Karen S. Hartl,Eddie Liu,Robert Zahler,Steven M. Seiler	2013	12
3	A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits Journal of Thrombosis and Thrombolysis ·Pancras C. Wong,Earl J. Crain,Carol A. Watson,William A. Schumacher	2011	61
4	Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Yan Shi,Jing Zhang,Mengxiao Shi,Stephen P. O’Connor,Sharon N. Bisaha,Chi Li,Doree Sitkoff,Andrew T. Pudzianowski,Saeho Chong,Herbert E. Klei,Kevin Kish,Joseph Yanchunas,Eddie C.‐K. Liu,Karen S. Hartl,Steve M. Seiler,Thomas E. Steinbacher,William A. Schumacher,Karnail S. Atwal,Philip D. Stein	2009	13
5	Biomarker Optimization to Track the Antithrombotic and Hemostatic Effects of Clopidogrel in Rats Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Jeffrey S. Bostwick,Martin L. Ogletree,Anne B. Stewart,Thomas E. Steinbacher,Ji Hua,Laura A. Price,Pancras C. Wong,Robert Rehfuss	2007	29
6	Abstract 631: Nonpeptide Factor XIa (FXIa) Inhibitor. In vitro Kinetic Evaluation and in vivo Studies of BMS-262084 on Arterial Thrombosis and Hemostasis in Rabbits Circulation ·Pancras C. Wong,William A. Schumacher,Carol A. Watson,Earl J. Crain,Martin L. Ogletree,Alan R. Rendina	2006	3
7	Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction Thrombosis Research ·Xinkang Wang,Mei-Yin Hsu,Thomas E. Steinbacher,Thomas M. Monticello,William A. Schumacher	2006	26
8	Effects of factor XI deficiency on ferric chloride‐induced vena cava thrombosis in mice Journal of Thrombosis and Haemostasis ·Xianyu Wang,Patricia L. Smith,M‐Y. HSU,David Gailani,William A. Schumacher,Martin L. Ogletree,Dietmar Seiffert	2006	112
9	Murine model of ferric chloride‐induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor Journal of Thrombosis and Haemostasis ·Xianling Wang,Patricia L. Smith,Mei-Yin Hsu,Martin L. Ogletree,William A. Schumacher	2006	77
10	Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice Journal of Thrombosis and Haemostasis ·Xianyu Wang,Qi Cheng,L. XU,G Feuerstein,M‐Y. HSU,Patricia L. Smith,Dietmar Seiffert,William A. Schumacher,Martin L. Ogletree,David Gailani	2005	233
11	Inhibition of Tumor Necrosis Factor-α-Converting Enzyme by a Selective Antagonist Protects Brain from Focal Ischemic Injury in Rats Molecular Pharmacology ·Xinkang Wang,Giora Feuerstein,Lin Xu,Hugh Wang,William A. Schumacher,Martin L. Ogletree,Rebecca Taub,James J.‐W. Duan,Carl P. Decicco,Rui‐Qin Liu	2004	70
12	Synthesis of potent and highly selective inhibitors of human tryptase Bioorganic & Medicinal Chemistry Letters ·William A. Slusarchyk,Scott A. Bolton,Karen S. Hartl,Ming‐Hsing Huang,G. A. JACOBS,Wei Meng,Martin L. Ogletree,Zulan Pi,William A. Schumacher,Steven M. Seiler,James Sutton,Uwe Treuner,Robert Zahler,Guohua Zhao,Gregory S. Bisacchi	2002	41
13	Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664 Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,S. David Kimball,Steven E. Hall,Wen-Ching Han,Edwin J. Iwanowicz,James C. Lin,Robert V. Moquin,Joyce A. Reid,John S. Sack,Mary F. Malley,ChiehYing Y. Chang,Saeho Chong,David Wang‐Iverson,Daniel G. Roberts,Steven M. Seiler,William A. Schumacher,Martin L. Ogletree	2002	10
14	Active site-directed synthetic thrombin inhibitors: synthesis, in vitro and in vivo activity profile of BMY 44621 and analogs. An examination of the role of the amino group in the D-Phe-Pro-Arg-H series Journal of Medicinal Chemistry ·Niranjan Balasubramanian,Denis R. St. Laurent,Marianne E. Federici,Nicholas A. Meanwell,John J. Wright,William A. Schumacher,Steven M. Seiler	1993	43
15	Thrombin inhibition compared with other antithrombotic drugs in rats Thrombosis Research ·William A. Schumacher,C.H. Heran,Thomas E. Steinbacher,J R Megill,J. Eileen Bird,Mary R. Giancarli,Stephen K. Durham	1992	10
16	The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin Basic Research in Cardiology ·G. J. Grover,Charles S. Parham,William A. Schumacher	1991	15
17	The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivo Inflammation Research ·William A. Schumacher,Joseph C. Fantone,Steve Kunkel,R. Clinton Webb,Benedict R. Lucchesi	1991	56
18	Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys. Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Christopher L. Heran,Karen S. Hartl,Martin L. Ogletree	1990	5
19	Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomolgus monkey. Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Harold Goldenberg,Don N. Harris,Martin L. Ogletree	1987	10
20	Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity. Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Benedict R. Lucchesi	1983	29

About William A. Schumacher

William A. Schumacher is a scholar working on Internal Medicine, Hematology and Genetics, having authored 82 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (24 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Venous Thromboembolism Diagnosis and Management (11 papers), Nitric Oxide and Endothelin Effects (10 papers), Inflammatory mediators and NSAID effects (10 papers), Cardiac Ischemia and Reperfusion (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). The work is most often cited by research in Hematology (800 citations), Internal Medicine (221 citations) and Genetics (620 citations). William A. Schumacher has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Martin L. Ogletree, Patricia L. Smith, Thomas E. Steinbacher, Dietmar Seiffert, Benedict R. Lucchesi, Christopher L. Heran, M‐Y. HSU, David Gailani, Xianyu Wang and Gary J. Grover. Their work appears in journals such as Circulation, Blood and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact